Preliminary gene expression analysis comparing pre- and post- gendicine-treated HNC tumor revealed upregulation of IFNγ-signaling genes, decreased TGF-β and β-catenin signaling (74) and increased CD8+ T cells signature, which is associated with increased clinical responses to ICIs (74). This evidence concerns the gene TGFB1 and neoplasm.